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Lytic polysaccharide monooxygenases (LPMOs) are a class of copper-
dependent enzymes discovered within the last ten years. They oxidatively
cleave polysaccharides (chitin, lignocellulose, hemicellulose and starch-derived),
presumably making recalcitrant substrates accessible to glycoside hydrolases.
Recently, the ﬁrst crystal structure of an LPMO–substrate complex was
reported, giving insights into the interaction of LPMOs with -linked substrates
(Frandsen et al., 2016). The LPMOs acting on -linked glycosidic bonds (family
AA13) display binding surfaces that are quite different from those of LPMOs
that act on -linked glycosidic bonds (families AA9–AA11), as revealed from
the ﬁrst determined structure (Lo Leggio et al., 2015), and thus presumably the
AA13s interact with their substrate in a distinct fashion. Here, several new
structures of the same AA13 enzyme, Aspergillus oryzae AA13, are presented.
Crystals obtained in the presence of high zinc-ion concentrations were used, as
they can be obtained more reproducibly than those used to reﬁne the deposited
copper-containing structure. One structure with an ordered zinc-bound active
site was solved at 1.65 A˚ resolution, and three structures from crystals soaked
with maltooligosaccharides in solutions devoid of zinc ions were solved at
resolutions of up to 1.10 A˚. Despite similar unit-cell parameters, small
rearrangements in the crystal packing occur when the crystals are depleted of
zinc ions, resulting in a more occluded substrate-binding surface. In two of the
three structures maltooligosaccharide ligands are bound, but not at the active
site. Two of the structures presented show a His-ligand conformation that is
incompatible with metal-ion binding. In one of these structures this conforma-
tion is the principal one (80% occupancy), giving a rare atomic resolution view
of a substantially misfolded enzyme that is presumably rendered inactive.
1. Introduction
Lytic polysaccharide monooxygenases (LPMOs) are a class of
copper-containing metalloenzymes that are able to oxidatively
cleave polysaccharides by oxidizing the pyranose units at C1
and/or C4. They have been found to act in synergy with
glycoside hydrolases (GHs; Harris et al., 2010) in the degra-
dation of polysaccharides and therefore have great potential
use in the utilization of biomass (Johansen, 2016; Hemsworth
et al., 2015). They possess a central -sandwich core and an
active site consisting of the N-terminal histidine and an
internal histidine, termed the histidine brace (Quinlan et al.,
2011; hereafter referred to as the His brace), which coordi-
nates a copper ion. The N-terminal histidine is often found to
be N"-methylated in fungi. The ﬁrst LPMO structures showed
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no obvious substrate-binding grooves as are commonly seen
for GHs (Vaaje-Kolstad et al., 2005; Karkehabadi et al., 2008;
Lo Leggio et al., 2012). The substrate has been found to
interact with the active site on a rather ﬂat surface (Aachmann
et al., 2012; Courtade et al., 2016) that may contain aromatic
residues proposed to mediate substrate interactions (Harris et
al., 2010; Li et al., 2012). The ﬁrst LPMOs discovered were
found to act on cellulosic substrates (Beeson et al., 2012;
Quinlan et al., 2011) or chitin (Vaaje-Kolstad et al., 2010), and
are now classiﬁed in the CAZy database (Lombard et al.,
2014) as enzymes with auxiliary activity (AA; created after
Levasseur et al., 2013) in the families AA9 (formerly GH61)
and AA10 (formerly CBM33). An additional chitin-active
family was later identiﬁed (AA11, deﬁned after Hemsworth et
al., 2014).
Later, structures of AA9s that are active on soluble
oligosaccharides [from Neurospora crassa (NcAA9C) and
Lentinus similis (LsAA9A)] showed a slightly more contoured
substrate-interacting surface than had been observed in the
ﬁrst AA9 structures (Frandsen et al., 2016; Borisova et al.,
2015). For AA9, substrate interaction at the proposed binding
surface (and the involvement of a conserved aromatic residue
in AA9) was categorically conﬁrmed with LsAA9A, as the
structure was solved in complex with cellooligosaccharides
(Frandsen et al., 2016). LsAA9A was the ﬁrst LPMO–
carbohydrate complex crystal structure to be published, thus
yielding insight into the LPMO–substrate interactions at this
interface and the general LPMO mode of action. The exact
catalytic mechanism is still not certain and possible mechan-
isms used by LPMOs have been discussed in recent reviews
(Lee & Karlin, 2015; Hemsworth et al., 2015; Walton & Davies,
2016).
Recently, a family of starch-degrading LPMOs was discov-
ered, which has now been classiﬁed as family AA13 in the
CAZy database. These starch-degrading LPMOs were ﬁrst
described in patent literature as having amylolytic-enhancing
activity (Harris & Wogulis, 2010) and were later demonstrated
to be LPMOs (Vu et al., 2014). The ﬁrst structural character-
ization of a member of the family came in 2015 for an LPMO
from Aspergillus oryzae (Lo Leggio et al., 2015; hereafter
denoted AoAA13). The published structure (Cu-AoAA13)
has copper bound at the active site, and displayed a shallow
groove at the putative substrate-binding surface instead of the
ﬂat surface commonly seen for all earlier LPMOs structures.
Recently, a review has been published highlighting the major
impact of structural studies in the investigation of LPMOs
(Frandsen & Lo Leggio, 2016).
Until the present study, no complexes of LPMOs with
-linked substrates were available. In the AoAA13 publica-
tion (Lo Leggio et al., 2015), activity was shown for a highly
sequence-related AA13 member from Aspergillus nidulans
(AnAA13) linked to a CBM20 (carbohydrate-binding module
family 20), a CBM family characteristic of starch binding
(Janecˇek et al., 2011; Christiansen et al., 2009). Members of
family AA13 are often linked to CBM20, and these CBMs
have been shown to bind starch substrates with afﬁnities
similar to those of the CBM20 associated with amylolytic
hydrolases (Nekiunaite et al., 2016). AnAA13 releases C1-
oxidized maltooligosaccharides [with a degree of poly-
merization (DP) of >4] from retrograded starch in the
presence of reducing cofactors. A 100-fold increased release of
maltose from retrograded starch by -amylases was also
demonstrated in the presence of AnAA13. Activity on starch-
related substrates (including corn starch, amylose, amylo-
pectin and maltodextrins) was additionally reported for an
AA13 from N. crassa (NcAA13; Vu et al., 2014), for which the
authors even speculated that some of the products originated
from C1-oxidation of the -1,6 linkages found in amylopectin.
For another AA13 fromAspergillus terreus (AtAA13), activity
has been demonstrated indirectly (Nekiunaite et al., 2016) by
inhibition of the Amplex Red assay (Kittl et al., 2012) in the
presence of -cyclodextrin and amylose (DP of 17).
AoAA13, in contrast to AnAA13, NcAA13 and AtAA13, is
a single-domain enzyme and, although no detectable activity
could be measured for AoAA13 (Lo Leggio et al., 2015), the
catalytic domain shares as much as 70–72% sequence identity
with those of AnAA13, NcAA13 and AtAA13. Here, we
present our attempts to obtain catalytically relevant crystallo-
graphic complexes of AoAA13 by soaking of maltooligo-
saccharides, the unexpected changes in local packing that we
observed in the course of these experiments, and the impli-
cations for active-site accessibility. We nonetheless obtained
high-resolution structures of AoAA13 interacting with small
maltooligosaccharides at distal binding sites and we discuss
their possible biological implications. We also present struc-
tures with a remarkably misfolded active site. In these struc-
tures, the active site adopts a non-native conformation that is
incapable of coordinating the active-site metal, thus presum-
ably rendering the enzyme completely inactive.
2. Materials and methods
2.1. Macromolecule production
AoAA13 production was as described in US patent appli-
cation US 2011/0283421 (Harris & Wogulis, 2010, 2011).
Details of expression and puriﬁcation are also provided in Lo
Leggio et al. (2015). For additional information, see Supple-
mentary Table S1.
2.2. Crystallization
Screening for crystallization conditions was performed in
MRC 2-drop crystallization plates (Molecular Dimensions) by
setting up 0.3 ml drops (with protein:reservoir ratios of 3:1 and
1:1) using an Oryx8 robot (Douglas Instruments). Initial
crystal hits were obtained with 6 mg ml1 protein in (i)
10%(w/v) PEG 3000, 0.2M zinc acetate, 0.1M sodium acetate
pH 4.5 and (ii) 20%(w/v) PEG 3000, 0.2M zinc acetate, 0.1M
imidazole pH 8.0, both from the JCSG+ Suite (Qiagen;
Supplementary Figs. S1a and S1b). Crystals were reproducible
with 2.4–6.0 mg ml1 protein in a range of 6–14%(w/v) PEG
3000 at pH 4.5 or in a range of 16–24%(v/v) PEG 3000 at pH
8.0. Because of the wide pH range in the otherwise similar
conditions, optimization were performed on the basis of pH by
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changing to buffer system II (a buffer system consisting of a
1:2:2 molar ratio of malic acid:MES:Tris) as described else-
where (Newman, 2004). The crystals were also found to be
reproducible with 20%(w/v) PEG 3000, 0.2M zinc acetate
when varying the pH from 4.0 to 9.0 with buffer system II
(Supplementary Fig. S1c). Crystals were further optimized by
setting up VDX plates with microseeding. The optimized
conditions were 20%(w/v) PEG 3000, 0.1M buffer system II
pH 5.0, 0.2M zinc acetate and 2.0–3.0 mg ml1 protein solu-
tion in a ratio of 3.0 ml protein solution to 1.0 ml reservoir
solution followed by immediate streak-seeding (Fig. 1).
From these crystals, a seed stock with reduced zinc content
was made [by transferring crystals into a solution consisting of
solely 20%(w/v) PEG 3000 and crushing them]. The seed stock
was used in a microseed matrix-screening approach along with
protein sample pre-incubated for 1 h with 1 mM copper(II)
acetate (as described in Lo Leggio et al., 2015, and references
therein). Crystals appeared in a condition devoid of zinc
[14%(v/v) 2-propanol, 30%(v/v) glycerol, 0.14M CaCl2,
0.07M sodium acetate pH 4.6] and, from these, the Cu-
AoAA13 structure (Lo Leggio et al., 2015) was determined.
Unfortunately, this procedure was not very reproducible and
the method was deemed to be unsuitable for the production of
a large number of similar crystals for the purpose of soaking
experiments.
Therefore, crystals prepared in VDX plates with 19–
21%(w/v) PEG 3000, 0.1M buffer system II pH 5.0, 0.2M zinc
acetate were used for soaking experiments with maltooligo-
saccharides (purchased from Sigma–Aldrich and Megazyme).
Initial soaks were carried out by adding maltooligosaccharide
stocks directly into the crystallization drops in a 1:1 volume
ratio. Crystals were soaked over various time spans (from
15 min to one week) in ﬁnal concentrations of either 0.1M
maltoheptaose, 0.1M maltopentaose or 0.5M maltose.
Another approach was also taken in which crystals [grown in
20%(w/v) PEG 3000, 0.1M buffer system II pH 5.0, 0.2M zinc
acetate] were transferred to a 2.0 ml drop consisting of solely
25%(w/v) PEG 3000 and 0.5M maltose. This was performed
research papers
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Figure 1
Crystals of Zn-AoAA13. These crystals were obtained in VDX plates using 20%(w/v) PEG 3000, 0.2M zinc acetate, 0.1M buffer system II pH 5.0.
Table 1
Data-collection statistics.
Values in parentheses are for the outer shell.
Zn-AoAA13 (unliganded) AoAA13-His91ﬂip AoAA13-G2(1,4) AoAA13-G3(1,4)G1(1,6)
Diffraction source ID14-4, ESRF I911-3, MAX-lab I911-3, MAX-lab I911-3, MAX-lab
Wavelength (A˚) 0.9334 1.0000 1.0000 0.9999
Temperature (K) 100 100 100 100
Detector CCD CCD CCD CCD
Crystal-to-detector distance (mm) 180.57 120.00 79.77 160.00
Rotation range per image () 1.0 1.0 0.5 1.0
Total rotation range () 180.0 200.0 193.5 180.0
Space group P212121 P212121 P212121 P212121
a, b, c (A˚) 47.04, 61.49, 73.79 45.56, 59.08, 71.76 45.40, 58.84, 71.90 45.67, 59.00, 72.15
, ,  () 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Mosaicity () 0.143 0.107 0.163 0.409
Resolution range (A˚) 30.00–1.65 (1.72–1.65) 30.00–1.30 (1.37–1.30) 30.00–1.10 (1.13–1.10) 30.00–1.60 (1.64–1.60)
Total No. of reﬂections 173493 (11020) 357103 (29842) 586098 (38851) 179873 (7069)
No. of unique reﬂections 26074 (2741) 47483 (6401) 78799 (5751) 26328 (1888)
Completeness (%) 98.7 (90.2) 98.2 (92.3) 99.9 (99.9) 99.7 (96.9)
Multiplicity 6.65 (4.02) 7.52 (4.66) 7.44 (6.76) 6.83 (3.74)
hI/(I)i 17.96 (2.11) 17.81 (3.59) 13.37 (2.99) 21.14 (3.14)
Rmeas (%) 8.8 (70.6) 8.2 (43.3) 12.9 (90.0) 7.5 (45.6)
CC1/2 (%) 99.9 (71.3) 99.9 (86.2) 99.9 (83.3) 99.9 (85.8)
Overall B factor from Wilson plot† (A˚2) 22.88 13.21 9.00 19.39
† Calculated using SFCHECK in the CCP4 suite.
electronic reprint
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Table 2
Structure reﬁnement and validation statistics.
Values in parentheses are for the outer shell.
Zn-AoAA13 (unliganded) AoAA13-His91ﬂip AoAA13-G2(1,4) AoAA13-G3(1,4)G1(1,6)
Resolution range (A˚) 30.00–1.65 (1.69–1.65) 30.00–1.30 (1.33–1.30) 30.00–1.10 (1.13–1.10) 40.00–1.60 (1.64–1.60)
Completeness (%) 98.72 (87.57) 98.1 (87.5) 99.9 (99.6) 99.4 (93.1)
No. of reﬂections, working set 25174 (1612) 45856 (2971) 76110 (5575) 25429 (1822)
No. of reﬂections, test set 900 (57) 1627 (113) 2677 (196) 906 (65)
Final Rcryst (%) 12.40 9.16 10.08 11.25
Final Rfree (%) 19.88 13.52 12.45 17.82
Cruickshank DPI 0.1198 0.0395 0.0243 0.0825
No. of non-H atoms
Protein 1896 2032 2088 1862
Ion 9 4 12 4
Ligand — — 23 45
Water 327 436 384 293
Total 2232 2472 2507 2204
R.m.s. deviations
Bonds (A˚) 0.0179 0.0191 0.023 0.018
Angles () 1.7140 1.9885 2.038 1.678
Average B factors (A˚2)
Protein† 15.580 8.643 7.361 11.711
Ion 23.612 13.696 10.065 13.975
Ligand — — 11.307 29.376
Water 25.639 24.733 25.485 23.609
Ramachandran plot‡
Most favoured (%) 88.9 90.9 91.9 91.4
Allowed (%) 11.1 9.1 8.1 8.6
† Glycosylation (a single N-acetylglucosamine unit) and the active-site metal are included in ‘Protein’. ‡ Calculated using PROCHECK in the CCP4 suite.
Figure 2
Substrate-binding groove in AoAA13 structures. Surfaces of residues involved in crystal contacts are coloured black in (b)–(f). (a, b) The Zn-AoAA13
structure (grey surface) with the proposed substrate-binding groove (residues 1, 25–31, 42–45, 49–55, 85–92, 166–176, 178–180, 189, 193 and 219–224)
coloured magenta. The His brace (H1 and H91) is indicated in light blue. (c) The Cu-AoAA13 structure coloured similarly to Zn-AoAA13. The active-
site copper is indicated by a copper-coloured surface. (d, e, f ) In AoAA13-G2(1,4) (green), AoAA13-G3(1,4)G1(1,6) (yellow) and AoAA13-
His91ﬂip (cyan), local changes in the crystal packing cause additional residues of the substrate-binding groove (including the His brace) to be involved in
crystal contacts. (g) The crystal contacts near the active site. Top: in Cu-AoAA13 or zinc-containing conditions (exempliﬁed by Zn-AoAA13) the His
brace is relatively accessible. Distances between the symmetry-related Glu16* backbone amide O and active-site metal (black dashes) are 6.3 and 6.4 A˚
for Zn-AoAA13 and Cu-AoAA13, respectively. Bottom: after transfer into conditions devoid of Zn (exempliﬁed here by AoAA13-His91ﬂip) the
Glu16*–Zn distance (black dashes) is shortened (3.9–4.1 A˚), thus limiting access to the groove and active site. For residues in (g) with alternative
conformations (except for the His brace) only the highest occupied conformation is shown.
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to heavily dilute the zinc concentration, as the zinc ions
present in the crystallization condition were speculated to
impair substrate binding (see x3). The same method was used
with longer maltooligosaccharides, transferring the crystals
to a 2.0 ml drop consisting of solely
25%(w/v) PEG 3000 and 50 mM
maltopentaose or 50 mM malto-
heptaose. Under these conditions, the
crystals soaked with the longer malto-
oligosaccharide had a tendency to
fragment; to prevent this, protein at low
concentration was included in the drop
for soaking. Introducing 1 mg ml1
protein into the soaking solution (still
without the zinc) made the crystals
much more amenable to the soaking
experiment, avoiding the problems of
cracking (although perhaps also
competing for oligosaccharide binding).
For soaks with branched substrates,
such as 63--d-glucosyl-maltotriose
(glucosyl-maltotriose) and 63--d-
glucosyl-maltotriosyl-maltotriose, crys-
tals were also moved to drops consisting
of 25%(w/v) PEG 3000, 1 mg ml1
AoAA13 protein and either 130 mM
63--d-glucosyl-maltotriosyl-maltotriose
or 125 mM glucosyl-maltotriose and
then soaked for 2 and 18 h, respectively,
before being mounted (Supplementary
Fig. S1d).
Cocrystallization screening was also
performed in which 20 mM malto-
pentaose was mixed (in an approximate
equimolar ratio) with AoAA13
(4 mg ml1) and incubated for 1 h. The
chosen conditions were optimized in
both MRC and VDX plates, varying
both the protein and precipitant
concentration. Crystals suitable for
mounting and data collection only grew
from the same condition as for the
ligand-free enzyme [namely 20%(w/v)
PEG 3000, 0.2M zinc acetate, 0.1M
imidazole pH 8.0] and were isomor-
phous to the previous crystals. Diffrac-
tion data were collected to 1.1 A˚
resolution on MX beamline I911-3 at
MAX-lab, but no bound maltopentaose
was found when inspecting the electron
density (not shown).
2.3. Data collection and processing
The data sets described here were
collected on beamline I911-3 at MAX-
lab, Lund, Sweden or on beamline
ID14-4 at ESRF, Grenoble, France, and were processed and
scaled using XDS and XSCALE (Kabsch, 2010) in space
group P212121, with unit-cell parameters similar to those of
Cu-AoAA13 (Lo Leggio et al., 2015). Several data sets were
research papers
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Figure 3
Structure of AoAA13-G2(1,4). (a) The AoAA13-G2(1,4) structure (green) interacting with
maltose along with a symmetry-related molecule (white) involved in crystal contacts near the active
site. (b) Disorder of the AoAA13-G2(1,4) metal-binding site with the metal-binding residues in
two conformations and the 2Fo  Fc map in blue. (c) Electron density for the maltose ligand
[2Fo  Fc map (blue) and Fo  Fc map (green)] calculated prior to incorporation of the ligand. In
both (b) and (c) the 2Fo  Fc and Fo  Fc maps are contoured at 1 and 3, respectively. (d)
Principal protein–ligand interactions in AoAA13-G2(1,4) and the position of maltose relative to
the His brace. Direct and water-mediated interactions (red spheres) with Arg53 and Ser188 (green
sticks) are shown. A symmetry-related maltose molecule (white) interacting with the 5–6 loop is
also shown. Zn-AoAA13 is shown for comparison (grey).
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collected, a selection of which are presented here. A data set
was collected to 1.65 A˚ resolution from a crystal that was not
soaked with ligand but was grown in the presence of zinc
(hereafter referred to as Zn-AoAA13). A crystal soaked (3 h)
in solely 25%(v/v) PEG 3000 and 0.5M maltose diffracted to
1.10 A˚ resolution [hereafter denoted AoAA13-G2(1,4)],
while a crystal soaked for 18 h in
25%(v/v) PEG 3000, 125 mM glucosyl-
maltotriose and 1 mg ml1 AoAA13
diffracted to 1.60 A˚ resolution [here-
after denotedAoAA13-G3(1,4)G1(1,6)].
Finally, a structure was obtained to
1.30 A˚ resolution (AoAA13-His91ﬂip)
from a crystal soaked with malto-
pentaose for 48 h but where further
analysis (see below) showed no malto-
pentaose density. Data statistics are
summarized in Table 1.
2.4. Structure solution and refinement
One round (20 cycles) of rigid-body
reﬁnement was run in REFMAC5
(Murshudov et al., 2011) from the CCP4
suite (Collaborative Computational
Project, Number 4, 1994; Winn et al.,
2011) using the previously solved
structure of Cu-AoAA13 (PDB entry
4opb; Lo Leggio et al., 2015) stripped of
water and other solvent molecules as
the model. Rfree ﬂags were also
imported from the previous structure-
factor ﬁle and extended to a higher
resolution limit when appropriate. The
preliminary structures were reﬁned by
multiple rounds of restrained reﬁne-
ment. The structures of both AoAA13-
G2(1,4) and AoAA13-His91ﬂip were
reﬁned anisotropically, while those of
AoAA13-G3(1,4)G1(1,6) and Zn-
AoAA13 were reﬁned isotropically for
all water molecules and anisotropically
for all other atoms (protein, metal ions,
glycosylation).
2.5. Structure analysis
Structures (and ligands) were
modelled, inspected and validated (e.g.
using Ramachandran plot, geometry
and rotamer analysis) in Coot (Emsley
& Cowtan, 2004; Emsley et al., 2010;
Debreczeni & Emsley, 2012). Zinc-ion
occupancies were modelled based on
their correlations with difference map
and anomalous Fourier map density, as
well as with appropriate B factors.
PROCHECK (Morris et al., 1992;
Laskowski et al., 1993), SFCHECK (Vaguine et al., 1999),
BAVERAGE and CONTACT (CCP4 suite) were also
used for ﬁnal structure validation and for crystal contact
analysis (looking for intermolecular contacts of 4 A˚).
Reﬁnement and validation statistics are summarized in
Table 2
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Figure 4
The AoAA13-G3(1,4)G1(1,6) structure. (a) The AoAA13-G3(1,4)G1(1,6) structure (yellow)
and a symmetry-related molecule (white) with the His brace (coloured according to molecule)
shown as sticks. The active-site Zn is shown as a sphere (grey). The glucosyl-maltotriose ligand is
bound in between the two molecules. (b) The His brace is shown in a native conformation (70%
occupancy) and in an alternative conformation (30% occupancy) as modelled in the ﬁnal structure.
The maps shown are 2Fo Fc (blue) and Fo Fc (green for positive and red for negative) difference
maps from a model with fully occupied His91A only, and are contoured at 1.0 and 3.0,
respectively. As shown, modelling a fully occupied native conformation leads to negative difference
map density near the active-site metal and positive difference map density near Phe166. (c)
Electron density for glucosyl-maltotriose calculated prior to incorporation of the ligand. The
2Fo Fc (blue) and Fo Fc (green) maps are shown at contour levels of 0.7 and 2.5, respectively.
(d) Glucosyl-maltotriose interactions with AoAA13 (yellow) and a symmetry-related molecule
(white). Principal direct interactions are formed through Gln82, Gln141 and Thr194 to Glc1 and
Glc3.
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3. Results
3.1. Overview of AoAA13 structures
Expressed and puriﬁed AoAA13 was crystallized and some
crystals were soaked with maltooligosaccharides. From an
unsoaked crystal, the unliganded zinc-bound structure (Zn-
AoAA13) was reﬁned. The structure reveals an active site with
two clearly deﬁned water ligands in the open equatorial and
axial positions with distances of 2.3 and 2.4 A˚, respectively.
The His brace [formed by the methylated His1 (meHis1) and
His91] coordinates the zinc in the other equatorial positions
with distances of 2.0–2.2 A˚, while the distance to Tyr224 in the
axial position is 2.4 A˚ (Supplementary Fig. S2a). All active-site
residues are well deﬁned and modelled in a
single conformation. The active site of
AoAA13 sits in a shallow groove (Fig. 2)
previously suggested to be involved in
substrate interactions (deﬁned as residues
1, 25–31, 42–45, 49–55, 85–92, 166–176, 178–
180, 189, 193 and 219–224 in Lo Leggio et
al., 2015). Although a number of alcohol
ligands (often carbohydrate mimics) were
found in the groove of the original Cu-
AoAA13 structure (PDB entry 4opb), the
role of the groove in substrate interaction
still needed to be experimentally conﬁrmed.
The Zn-AoAA13 structure (as well as
that of Cu-AoAA13) shows that the area
near the active site is involved in crystal
contacts. Analysing the interfaces of
Zn-AoAA13 using PISA reveals three
signiﬁcant interfaces of >150 A˚2, of which
one is involved in crystal contacts only at
the border of the groove [the residues
involved in crystal contacts in Zn-AoAA13
(Glu29, Pro30, Phe166, Glu167, Gln219 and
Thr220) are similar to those in Cu-AoAA13
;Fig. 2]. Thus, the groove and active site
were relatively accessible, providing the
rationale for soaking experiments (cocrys-
tallization experiments with maltopentaose
did not result in structures with bound
ligands; see x2).
Data collected from crystals in the initial
soaking experiments (not shown) showed
no difference density in the initial electron-
density maps that could account for
maltooligosaccharides. One cause of
concern was that the high concentration of
zinc ions in the crystallization condition
prevented binding, since many ions were
seen to be bound to the surface of the
protein in the Zn-AoAA13 structure, in
contrast to the Cu-AoAA13 structure
obtained using a different, but not very
reproducible, crystallization procedure (see
x2 for details).
Thus, soaking with a solution depleted of zinc ions was
performed. This proved to be successful when soaking with
maltose, since AoAA13-G2(1,4) clearly showed the presence
of very well deﬁned electron density for maltose between two
symmetry-related molecules, which could be modelled with
90% occupancy (Figs. 3a and 3c). In general, structures
obtained from crystals soaked in conditions devoid of zinc
contained fewer Zn atoms in the structure (Supplementary
Table S2).
With this result in mind, it was obvious to try to use the new
procedure for soaking to achieve complexes with longer and
branched maltooligosaccharides. Unfortunately, soaking
experiments with maltopentaose and maltoheptaose resulted
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Figure 5
Active site of AoAA13-His91ﬂip. (a) The protein is shown in cyan with the His brace as sticks.
The active-site residue His91 is modelled in a native (H91B) and non-native (H91A)
conformation with 20 and 80% occupancy, respectively. (b) The 2Fo  Fc (blue, at 1.0) and Fo
 Fc (green, at 2.0) maps shown as calculated for the fully occupied ﬂipped conformation of
His91 (100% occupancy of H91A). The fully ordered active site of Zn-AoAA13 (grey) is shown
for comparison. (c) The active site of AoAA13-His91ﬂip (the Thr220–Gln222–Tyr224 and
Gly89–meHis1 interactions are lost) compared with Zn-AoAA13. The 5–6 loop moves away
from the active site. His91 ﬂips out of the active site (H91A), interacting with Phe166. The
vacant position of H91A is partly occupied by Gln222 and Gly89, which lose interactions with
the active-site residues meHis1 and Tyr224.
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in neither of the ligands being bound in the structures. For
branched oligosaccharides the method was to some extent
successful when soaking with glucosyl-maltotriose as, in
unbiased 2Fo  Fc and Fo  Fc maps at 0.7 and 2.5,
respectively, the density was relatively well deﬁned for the
maltotriose portion (Fig. 4c). In the ﬁnal reﬁned structure of
AoAA13-G3(1,4)G1(1,6) the glucosyl-maltotriose ligand
was modelled with 70% occupancy.
For the data sets collected from soaked crystals, oligo-
saccharide ligands were found only in two structures, namely
AoAA13-G2(1,4), further described in x3.2, and AoAA13-
G3(1,4)G1(1,6), further described in x3.3. In these struc-
tures some disorder of the His brace and other residues near
the active site is observed, as will be described in more detail
below. For one of the crystals soaked with maltopentaose,
although no obvious oligosaccharide binding occurred, the
observed disorder is extreme. The principal conformation of
His91 (80% occupancy) was ﬂipped away from meHis1,
resulting in a completely misfolded active site (Fig. 5a). The
structure was named AoAA13-His91ﬂip based on this obser-
vation, and is further described in x3.4.
The three structures obtained with
crystals from zinc-depleted soaking
conditions show local changes in the
crystal packing (Fig. 2g) compared with
the Zn-AoAA13 and Cu-AoAA13
structures. These changes were not
observed for crystals from the same
tray soaked with maltose in the
presence of Zn for even as long as a
week, so the changes are not attribu-
table to the presence of oligosacchar-
ides alone. In AoAA13-G2(1,4),
AoAA13-G3(1,4)G1(1,6) and AoAA13-
His91ﬂip the molecular interfaces
reported by PISA were somewhat
larger than for Zn-AoAA13 (and Cu-
AoAA13), and additional groove resi-
dues in the vicinity of the active site, as
well as the His brace itself (His1, Asn88,
Gly89, His91 and Gln222 in Fig. 2), were
reported to be involved in crystal
contacts, despite the similar unit-cell
parameters. Although this new packing
limits the access to the active site, large
parts of the proposed substrate-binding
groove still appeared to be largely
accessible (e.g. in between Glu29,
Pro30, Arg44, Phe50 and Ala52 in
Fig. 2). Surprisingly, though, bound
ligands were only found outside the
proposed substrate-binding groove.
3.2. Binding of the maltose ligand
In AoAA13-G2(1,4) maltose is
found between two symmetry-related
molecules (Fig. 3 and Table 3). Analysis with PISA reveals
that one molecule has a slightly higher surface interface with
maltose. Assigning maltose to the molecule with the greater
interaction interface places it somewhat within reach of the
active site (Fig. 3).
Two amino acids are potentially within hydrogen-bonding
distance of the maltose moiety, namely Arg53 and Ser188
(Fig. 3). In AoAA13-G2(1,4) Arg53 is less well deﬁned than
in the native structure (Cu-AoAA13), and although the Fo Fc
density did suggest that Arg53 also exists in a partial confor-
mation within hydrogen-bonding distance of the maltose
ligand, the residue was modelled in one conformation similar
to that of Cu-AoAA13. The Arg53 side chain comes within a
distance of 3.4 A˚ of the C1 hydroxyl from the glucosyl unit
from the reducing end (hereafter denoted Glc1). The Arg53
residue is involved in water-mediated hydrogen bonds to both
Glc1 O1 and Glc1 O2. Additional hydrogen bonds are gained
through another water molecule from Glc1 O4 (the glycosidic
linkage) and Glc2 O2 to both Arg53 and Ser21. Ser188 makes
a 2.7 A˚ hydrogen bond to Glc1 O1 and a water-mediated
hydrogen bond to Glc1 O6 (Fig. 3). Hydrogen bonds are also
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Table 3
AoAA13 interactions with maltose.
AoAA13-G2(1,4)
Glycosidic
atom Residues (bck/sc†) Protein atom‡
Distance
(A˚)
Interaction
type
Glc1 (1,4) O1 Ser188(sc) O 2.7 Direct
O1 Arg53(sc) N 3.4 Direct
O1 Arg53(sc) H2O (N
) 2.9 Mediated
O2 Arg53(sc) H2O (N
) 2.6 Mediated
O4 Arg53(sc)/Ser21(sc) H2O (N
/O) 3.1 Mediated
O5 Ser188 (bck) O 3.3 Direct
O5 Ser188(bck) H2O (O) 3.1 Mediated
O6 Ser18(bck) H2O (O) 2.8 Mediated
Glc2 (1,4) O2 Arg53(sc)/Ser21(sc) H2O (N
/O) 3.1 Mediated
O3 Asp54(sc)/Asn219(bck)§ H2O (O
/O) 2.7 Mediated
O4 Phe218(bck)§ O 2.7 Direct
O5 Ser32(sc)§ H2O (O
) 2.8 Mediated
O6 Ser32(sc)§ H2O (O
) 3.2 Mediated
O6 Ser33(bck)§ N 3.1 Direct
† Backbone (bck)/side chain (sc). ‡ For water-mediated protein–ligand interactions the protein atom interacting with
the water molecule is given in parentheses. § Symmetry-related.
Table 4
AoAA13 interaction with glucosyl-maltotriose.
AoAA13-G3(1,4)G1(1,6)
Glycosidic
atom Residues (bck/sc†) Protein atom‡
Distance
(A˚) Interaction type
Glc1 (1,4) O1 Gln141(sc) O" 2.5 Direct
O2 Glu142(bck) H2O (N) 2.5 Mediated
O4 Thr196(bck)/Asp178(sc) H2O (O/O
) 3.0 Mediated
Glc2 (1,4) O2 Thr196(bck)/Asp178(sc) H2O (O/O
) 2.8 Mediated
O6 Asp111(sc)§ O" 2.9 Direct
Glc3 (1,4) O3 Thr194(sc) O 2.7 Direct
O4 Gln82(sc) N" 2.9 Direct
O4 Ser184(bck) H2O (O) 2.7 Mediated
Glc4 (1,6) O2 Asp111(sc)§ O 2.4 Mediated
O3 Lys108(sc)§ N 3.0 Direct
O3 Ser104(bck)§ H2O (O) 2.8 Mediated
† Backbone (bck)/side chain (sc). ‡ For water-mediated protein–ligand interactions the protein atom interacting with
the water molecule is given in parentheses. § Symmetry-related.
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made to Glc2 from the peptide backbone of a symmetry-
related molecule (Fig. 3, white). The backbone amide N atom
of Ser33* (residues from symmetry-related molecules are
indicated with asterisks) contacts Glc2 O6, while Ser32*
makes a water-mediated hydrogen bond (bidentate) to both
Glc2 O6 and Glc2 O5. Lastly, the amide O atoms of Phe218*
and Gln219* (in the loop connecting 5 and 6 in Fig. 3) make
hydrogen bonds (direct and water-mediated) to Glc2 O4 and
Glc2 O3, respectively. All interactions are summarized in
Table 3.
Some disorder of the active-site residues is observed in this
structure (a main and an alternate conformation were
modelled with 80 and 20% occupancy, respectively, for each of
meHis1, His91, Gln222 and Tyr224), although all alternate
conformations are close in space to the main conformation.
Since the maltose complex is one of the highest resolution
LPMO structures to date, and this would be mechanistically
interesting [especially in the light of an observed hydrogen-
bonding network in the active site of the LsAA9A complex
structures (Frandsen et al., 2016) and the proposed
tautomerization of the terminal amine of meHis1 during
catalysis (Gagnon & Tolman, 2015; Walton & Davies, 2016;
Dhar & Tolman, 2015)], we checked to see whether hydrogen
could be clearly identiﬁed in a difference map. Indeed, many
H atoms are clearly visible in well ordered regions (Supple-
mentary Figs. S2b and S2c), but unfortunately this is not the
case at the active site owing to the observed disorder.
3.3. Binding of the glucosyl-maltotriose ligand
The AoAA13-G3(1,4)G1(1,6) structure showed the
bound glucosyl-maltotriose ligand interacting with two mole-
cules but quite far from the active site of both (Fig. 4a and 4c).
Analysis with PISA reveals that one molecule has a greater
surface interface with the maltotriose part of the ligand. The
same molecule also makes the most polar interactions with the
ligand (Table 4). Only the -1,6-linked glucose branch (Glc4)
has a greater interface with a symmetry-related molecule (Fig.
4d). Based on this, the glucosyl-maltotriose was assigned to the
molecule with the most interactions. The only three amino-
acid residues that come within reach of hydrogen-bonding
distance (3.2 A˚) are Gln82, Gln141 and Thr194 (Fig. 4). The
ﬁrst glucose residue (from the reducing end; hereafter denoted
Glc1) of the ligand interacts via the C1 hydroxyl (Glc O1) with
Gln141 through a 2.5 A˚ hydrogen bond. An additional inter-
action is gained from a water-mediated hydrogen bond to the
backbone amide of Glu142. Both Glc1 O4 (glycosidic bond)
and Glc2 O2 make water-mediated bidentate hydrogen bonds
to Asp178 O and the backbone amide of Thr196. Glc2 O6
comes within reach (distance 2.9 A˚) of Asp111* O from a
symmetry-related molecule, although the geometry is slightly
unfavourable for a hydrogen bond (C6—O6—Asp111* O
angle of 80). An additional 2.9 A˚ contact to the same
symmetry-related molecule exists between Glc2 O5 and
Pro112* C (which seems unfavourable). Glc3 O3 makes the
strongest interaction (distance of 2.7 A˚) to Thr194 O, while
Glc3 O4 makes a hydrogen bond with a distance of 2.9 A˚ to
Gln82 N". It also makes an additional water-mediated
hydrogen bond (2.7 A˚) to the carbonyl of Ser184. Glc4, the
least well deﬁned residue, makes hydrogen bonds (two water-
mediated and one direct with Lys108*) to a symmetry-related
molecule. All interactions are summarized in Table 4.
There is also a disordered active site in the AoAA13-
G3(1,4)G1(1,6) structure. However, unlike in AoAA13-
G2(1,4), where all alternate conformations of the active-site
residues are close to the main conformations, here His91 had
to be partly modelled in a conformation ﬂipped away from the
active site (H91B, with 30% occupancy, in Fig. 4b;
His91A N"—His91A/B C—His91B N" angle of 115)
where it does not interact with the active-site metal ion.
3.4. AoAA13-His91flip structure
As described above, in the Zn-AoAA13 structure the
active-site residues (meHis1, His91 and Tyr224) are fully
ordered, while in the complex structures obtained from
soaking in zinc-depleted conditions, AoAA13-G2(1,4) and
AoAA13-G3(1,4)G1(1,6), some disorder of active-site
residues is observed.
The AoAA13-His91ﬂip structure presents an extreme case
of active-site disorder, where the main conformation of His91,
with 80% occupancy (H91A in Fig. 5), is ﬂipped120 relative
to the native conformation in which it can bind the active-site
metal. There is, however, evidence for a 20% occupancy of the
native metal-binding conformation, since modelling a fully
occupied ﬂipped conformation of His91 leads to negative
density in the Fo Fc map, while positive density appears near
the active-site metal (Fig. 5b).
Other differences can be seen compared with the Zn-
AoAA13 structure. In the Zn-AoAA13 structure Gln222 and
Gly89 interact with Tyr224 and meHis1, respectively (Fig. 5c).
In AoAA13-His91ﬂip, His91A makes favourable 	–	 stacking
interactions with Phe166 (Fig. 5c). At the active site the
Thr220–Gln222–Tyr224 and the Gly89–meHis1 interactions
are lost, and Gln222 and Gly89 move towards the metal site,
ﬁlling the empty space left by the movement of His91A
(Fig. 5c). The 5–6 loop (harbouring Thr220) moves away
from the active site compared with Zn-AoAA13. Effectively,
the active site is severely misfolded compared with a metal-
binding conformation.
4. Discussion
4.1. Biological relevance of oligosaccharide-bound structures
In the AoAA13 structures presented here, none of the
maltooligosaccharides interact directly with the active site
(Fig. 6). A possible reason is that the local changes in crystal
contacts occurring in structures from zinc-depleted conditions
further limit access to the active site (Fig. 2).
The biological signiﬁcance of the liganded structures is
uncertain. Although a maltose residue comes within close
distance of meHis1 in one complex (Fig. 3), the structures
obtained here obviously do not mimic Michaelis–Menten
complexes. This is in contrast to the LsAA9A complex
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structures (PDB entries 5acf, 5aci and 5acj), where the scissile
glycosidic bond is positioned in the active site with the
glucosyl unit in subsite +1 stacking with meHis1. When
superimposing the LsAA9A complex structures onto
AoAA13 it is clear that structural features in AoAA13 (e.g.
the side chain of Ile189; Fig. 2) interfere with the -linked
substrates in subsite +2. However, since AA13s act on
-linked glycosidic linkages, it is possible that AoAA13 could
accommodate -linked substrates making stacking inter-
actions with meHis1.
The maltose ligand in the AoAA13-G2(1,4) structure has
the reducing-end C1 hydroxyl (Glc1 O1) pointing towards the
protein molecule, but it is possible that a slightly altered mode
of binding would allow an -1,4-linked substrate to extend
towards the active site. Thus, the maltose ligand in AoAA13-
G2(1,4) could resemble binding in distant subsites (Fig. 6). In
this regard it must be noted that the direction of the substrate
(in terms of the reducing/nonreducing ends) would be the
opposite of that in the LsAA9A complex structures. In the
light of the reported amylopectin activity (Vu et al., 2014), it is
also possible that extending the substrate through an -1,6
linkage from Glc1 O6 of the maltose ligand could lead to the
active site (Fig. 6), and thus the ligand could mimic interaction
with a branched substrate such as amylopectin. The residues
Arg53 and Ser188 (which interact directly with the maltose
ligand) are almost completely conserved among AA13
members (Arg and Ser/Thr; Supplementary Fig. S3),
supporting the relevance of this binding site. However, all of
these suggestions remain highly speculative until further
experimental evidence is acquired.
In the case of AoAA13-G3(1,4)G1(1,6) the ligand is
found quite far from the active site (Figs. 4a and 6). Inter-
actions far from the active site were also found for NcAA9C
(PDB entry 4d7u), where substrate titrations (with xyloglucan
polysaccharides) were monitored using NMR (Courtade et al.,
2016). Some of these interactions
appear to be in similar positions
as the interactions with glucosyl-
maltotriose found in AoAA13-
G3(1,4)G1(1,6). Recently,
secondary binding sites (termed
surface binding sites; SBSs) have
been recognized in several GH
families, for example GH13 and
GH77 (Cockburn et al., 2014;
Cuyvers et al., 2012). These are
sites distant from the active site
which have an indirect positive
effect on the turnover of the
substrate through a variety of
functions, such as substrate
targeting, enhancing processivity
and allosteric effects (Cockburn
et al., 2014; Cuyvers et al., 2012).
A common architecture of SBSs
usually involves two aromatic
residues positioned parallel to the
enzyme surface with an angle of about 130 between them.
The concave curvature is proposed to assist by accompanying
the helical starch structures, and the motif is also shared with
several starch-binding modules (Cuyvers et al., 2012). The
AoAA13-G3(1,4)G1(1,6) structure could represent a
similar secondary binding site for either branched or
nonbranched substrates. The highly conserved Gln82, Gln141
and Thr194 (Supplementary Fig. S3) in AA13 members
support the relevance of this proposed site, although the
absence of aromatics is atypical for SBSs. It must be noted that
LPMOs in general have very atypical substrate-binding
surfaces compared with other carbohydrate-active enzymes.
There is, for example, a general paucity of Trp residues on the
surfaces of LPMOs.
No traces of maltose or maltopentaose were found at the
G3(1,4)G1(1,6) binding site in any of the remaining struc-
tures. In AoAA13-G3(1,4)G1(1,6) the most prominent
protein interactions with the maltotriose part of the ligand are
gained from Gln82, Gln141 and Thr194 to Glc1 and Glc3
(Fig. 4 and Table 4); therefore, it is possible that -1,4-linked
substrates with a DP of <3 will interact too weakly at this site.
The C4 hydroxyl at the nonreducing end of the maltotriose
part, Glc3 O4 (Fig. 6), is not obstructed, and thus there is
sufﬁcient space in the crystal for maltopentaose (or other
-1,4-linked substrates with a DP of >3) to bind. However,
maltopentaose lacks the -1,6-linked glucosyl unit which is
also likely to aid binding, which may explain why malto-
pentaose did not bind.
Given the additional occlusion of the His brace in the
crystals after rearrangement of the crystal packing in the
described complexes, our results do not support, or disprove,
the previously proposed AA13 binding site. Parts of the
proposed substrate-binding groove were accessible, but no
ligands were found here. Additional factors that could explain
the lack of binding are that the oligosaccharides used in this
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Figure 6
Maltooligosaccharide ligands bound in the AoAA13 structures. The Zn-AoAA13 structure is shown in
grey, with the surface of the substrate-binding groove (residues 1, 25–31, 42–45, 49–55, 85–92, 166–176, 178–
180, 189, 193 and 219–224) coloured magenta. The His brace and active-site zinc are shown as sticks and a
sphere, respectively, and are indicated with a light blue surface. The maltose ligand of AoAA13-G2(1,4)
(green) and the glucosyl-maltotriose ligand ofAoAA13-G3(1,4)G1(1,6) (yellow) are superimposed onto
the Zn-AoAA13 structure and shown in sticks to indicate their positions relative to each other and to the
substrate-binding groove.
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study are too poor mimics of the natural substrate, and that
under the soaking conditions the active site is disordered (see
x4.2). It is also possible that the conditions used here are
inappropriate for ligand binding (note that the addition of
NaCl and HCN enhanced substrate binding for LsAA9A and
NcAA9C, respectively; Frandsen et al., 2016; Courtade et al.,
2016). Considering all of the evidence, it is possible that the
maltooligosaccharide-binding sites observed in the presented
structures represent interactions with extended biologically
relevant substrates (such as, for example, amylopectin or
amylose), but given their position at symmetry contacts the
ligands may also represent artefacts in the crystalline state.
4.2. Disordered active site
The disorder of the active site and movement of the 5–6
loop (Figs. 5c and 3d) appear to correlate with an absence of
active-site metal. Zinc is a good redox-inactive mimic of
copper at LPMO active sites, and this was another reason why
soaking in zinc-substituted AoAA13 seemed attractive at the
beginning of this project, since the enzyme would deﬁnitely be
inactive and the disorder often observed in LPMO structures
owing to the photoreduction of copper would be avoided.
However, the His brace has lower afﬁnity for zinc ions than for
copper ions (Hemsworth et al., 2013, 2014; Lo Leggio et al.,
2015; Quinlan et al., 2011; Aachmann et al., 2012), and it is
clear that the zinc concentrations under the soaking conditions
employed here were insufﬁcient to maintain a fully occupied
metal site.
In the uncomplexed structures Cu-AoAA13 and Zn-
AoAA13 with a fully occupied active-site metal, the active-site
residues are ordered and interact with the 5–6 loop via
hydrogen bonds between the backbone amides of His91 and
Gln219 and between the side chains of Thr220, Gln222 and
Tyr224 (Fig. 5c). In the absence of metal the active-site
disorder interferes with these interactions and leads to
movement of the 5–6 loop (Figs. 3d and 5), which occurs for
all of the three structures obtained under zinc-depleted
conditions [AoAA13-G2(1,4), AoAA13-G3(1,4)G1(1,6)
and AoAA13-His91ﬂip]. Apparently, this allows the local
changes in the crystal packing and additional crystal contacts
(with meHis1, Asn88 and His91, and in some cases also Gly89
and Gln222) at the active site and proposed substrate groove
(Fig. 2) [the crystal contacts with Gly89 are formed in the
AoAA13-G3(1,4)G1(1,6) and AoAA13-His91ﬂip struc-
tures following the rearrangement of His91; Fig. 5]. This
explains the increased crystal lattice interface (reported by
PISA) in these three structures.
Despite the relatively tight packing around His91 in the
three structures from soaked crystals, Zn-AoAA13 has fewer
crystal contacts around the His brace (Fig. 2g), and it is
conceivable that even more extreme ﬂipping of His91 could
occur in situ. However, it is also possible that the more drastic
His91 rearrangement seen only in some structures is an effect
related to the long storage of the apoprotein sample, since
apart from Zn-AoAA13 the structures presented here were
obtained using a protein batch stored for some time in the
absence of divalent metals. For other families of LPMOs it has
been reported that copper binding increases protein stability
(Gregory et al., 2016; Johansen et al., 2012). Copper was not
included in in the storage buffer as this could lead to undesired
Fenton chemistry if trace amounts of promiscuous electron
donors were present. Indeed, for some families of LPMOs it
has been shown that copper-loaded enzymes in the absence of
substrate produce H2O2 (and potentially other protein-
damaging reactive oxygen species; Kittl et al., 2012; Isaksen et
al., 2014; Bennati-Granier et al., 2015), which can lead to
enzyme inactivation (Scott et al., 2016).
The absence of an active-site metal has been reported to
decrease the rigidity of the active-site residues in other
LPMOs (Aachmann et al., 2012; Vaaje-Kolstad et al., 2005;
Hemsworth et al., 2013; Chiu et al., 2015). Structures of AA10s
from Bacillus amyloliquefaciens (BaAA10A; Hemsworth et
al., 2013) and Enterococcus faecalis (EfAA10A; Vaaje-Kolstad
et al., 2012; Gudmundsson et al., 2014) have copper-bound
active sites (PDB entries 2yoy and 2yox, and PDB entries 4alc
and 4alt, respectively) which are very similar to those of Cu-
AoAA13 (and Zn-AoAA13). However, the BaAA10A and
EfAA10A apo structures (PDB entries 2yow and 4a02,
respectively) show a repositioning of the internal active-site
histidines (His125 in BaAA10A and His114 in EfAA10A).
Interestingly, these histidines interact with residues (Asp191 in
BaAA10A and Asp180 in EfAA10A) in a loop equivalent to
the 5–6 loop in AoAA13. Furthermore, in a recent EPR
study, heterogeneity of the active site of an AA10 is reported
(Chaplin et al., 2016). The authors report two distinct copper-
bound forms that differ in the coordination of the amino
group of the N-terminal His (i.e. three-coordinated and two-
coordinated copper, respectively). The structure of an AA9
from Thermoascus aurantiacus (TaAA9A; PDB entry 3zud)
shows the active-site copper modelled in two (quite different)
conformations, one of which has an N–metal distance of
>4.0 A˚ (Quinlan et al., 2011). Similarly, the AoAA13-G2(1,4)
active-site metal (although zinc in this case) and His brace are
also modelled in two conformations. It is, however, not clear
whether the difference in N–metal distances (0.1 A˚) of the two
conformations in AoAA13-G2(1,4) is signiﬁcant (as is the
case for TaAA9A, where it is 1.4 A˚). From this it seems that
the plastic nature of the AA13 active site described here is
shared with members of other families and perhaps is a
general feature of LPMOs.
5. Conclusion and perspectives
In this study, we set out to obtain substrate complexes with the
zinc-substituted form of an AA13 family enzyme. The initial
efforts were hampered by an excess of zinc ions in the putative
substrate-binding groove. A strategy in which soaks were
carried out in solutions depleted of zinc ions showed un-
expected local rearrangements of crystal packing, which
occlude the histidine brace. Furthermore, we observed active-
site disorder, which in its most extreme case caused a severe
rearrangement of the internal His of the His brace. The
AoAA13-His91ﬂip structure provides a rare example of a
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three-dimensional structure of a heavily misfolded enzyme
active site, and highlights the important role of the active-site
metal in terms of maintaining a native fold. Both His-brace
occlusion and disorder are likely to interfere with oligo-
saccharide binding. Nonetheless, complexes were obtained
with two oligosaccharides, although they do not interact with
the His brace. These complexes might simply be crystal arte-
facts. However, owing to the unusual nature of LPMO binding
surfaces and the unknowns regarding the natural substrates of
AA13, it is also possible that these sites represent unusual SBS
or binding sites for branched substrates. Further strategies on
obtaining biologically relevant complexes with AoAA13 will
have to take into account the effects of metal ions in the
packing of the so far only observed crystal form of the enzyme,
and also consider the possible effects of long-term storage on
the crystallized conformations.
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